A leading global pharmaceutical and medical device company, Sanofi leverages MIT LGO to improve their production of devices as well as vaccines. Sanofi’s state-of-the-art injection pen production facility near Frankfurt, Germany, is a prime site for the LGO-Sanofi relationship. In the facility, Sanofi is developing a smoother way to administer insulin to diabetes patients, and LGOs have made an impact by identifying innovative ways to eliminate device defects. LGO students also make important contributions to vaccine production as part of an overall digital transformation process within Sanofi.
Ismael Guerca Valdivi (LGO ’24)
Title: Preemptive Variation Reduction in Biologic Drug Substance Manufacturing
Engineering Department: Chemical Engineering
Ana Haddad (LGO ’24)
Title: Optimizing Multiproduct Drug Substance Production for Increased Throughput
Engineering Department: Mechanical Engineering
Sanofi looks to hire LGO students into a range of operations and product roles across their business units.
